FDA
- Marketing authorisation holder: NOVARTIS
- Status: approved
🇺🇸 Antrenyl in United States
Antrenyl (OXYPHENONIUM) regulatory status in United States.
Marketing authorisations
FDA
- Application: NDA008492
- Marketing authorisation holder: NOVARTIS
- Local brand name: ANTRENYL
- Indication: TABLET — ORAL
- Status: approved
Antrenyl in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Antrenyl approved in United States?
Yes. FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Antrenyl in United States?
NOVARTIS holds the US marketing authorisation.